Balyo (BALYO) Q4 2024 TU earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 TU earnings summary
6 Jun, 2025Executive summary
2024 sales increased by 9% to €29.1 million, driven by strong Q4 growth and direct sales focus.
Direct sales accounted for 86% of annual order intake, with the US becoming the largest market.
Successful €36.6 million capital increase in November 2024 strengthened the balance sheet.
Financial highlights
Q4 2024 sales rose 22% year-over-year to €8.3 million; full-year sales reached €29.1 million, up from €26.7 million in 2023.
Order intake for 2024 was €26.9 million, down 26% year-over-year due to an unfavorable base effect.
Backlog stood at €21.9 million as of December 31, 2024.
Cash position at year-end was €22.6 million, up from €5.5 million at September 30, 2024.
Outlook and guidance
Plans to accelerate direct sales model deployment in 2025 to drive further sales growth.
Focus on innovation and maintaining a controlled cost structure in the coming year.
Latest events from Balyo
- 2025 revenue rose 8% to €31.4M, with US sales up 41% and SoftBank providing key financing.BALYO
H2 202519 Mar 2026 - Gross margin rose to 30% as revenue fell and order backlog surged, but losses continued.BALYO
H1 20251 Oct 2025 - Order intake and backlog surged despite a 4% revenue dip, led by strong US momentum.BALYO
H1 2025 TU17 Jul 2025 - Sales declined and losses deepened, prompting a €36M capital raise to secure liquidity.BALYO
H1 202413 Jun 2025 - Backlog up 73% to €17.9M, but H1 sales fell 7% and going concern risk remains.BALYO
Q2 2024 TU13 Jun 2025 - 2024 sales up 9% to €29.1M, but net loss deepened as margins declined.BALYO
H2 20246 Jun 2025